Effects of Pyrimethamine Versus Proguanil in Malarial Chemoprophylaxis in Children with Sickle Cell Disease: A Randomized, Placebo-Controlled, Open-Label Study

Current Therapeutic Research - Clinical and Experimental

Volumn 64, Issue 8, 2003, Pages 616-625

  Eke, Felicia U ^a   Anochie, Ifeoma ^a  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Malarial chemoprophylaxis; Proguanil; Pyrimethamine; Sickle cell disease

Indexed keywords

PROGUANIL; PYRIMETHAMINE;

ADOLESCENT; AFRICA; ARTICLE; BONE PAIN; CHEMOPROPHYLAXIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; HEMOLYTIC ANEMIA; HEPATOMEGALY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; NIGERIA; PARASITE TRANSMISSION; PARASITEMIA; PARASITOSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; SEPTICEMIA; SICKLE CELL ANEMIA; SPLENOMEGALY; STATISTICAL SIGNIFICANCE; TABLET;

EID: 0345376915     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2003.09.003     Document Type: Article

References (27)

1. Salako LA. Severe complicated malaria. Mal Inf Dis Afr. 1994;1:22-23.
2. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: Cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg. 2001;64(Suppl 1-2):57-67.
3. Barsoum RS. Malarial nephropathies. Nephrol Dial Transplant. 1998;13:1588-1597.
4. Serjeant GR. Sickle-cell disease. Lancet. 1997;350:725-730.
5. Ambe JP, Fatunde JO, Sodeinde OO. Associated morbidities in children with sickle-cell anaemia presenting with severe anaemia in a malarious area. Trop Doct. 2001;31:26-27.
6. Serjeant GR. The role of preventive medicine in sickle cell disease. The Watson Smith lecture. J R Coll Physicians Lond. 1996;30:37-41.
7. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. In: Cochrane Database Systems Review [CD-ROM]. 2000;2:CD000363.
8. Federal Ministry of Health. Guidelines for Malarial Control in Nigeria. 1989:1-42.
9. Nahlen BL, Akintunde A, Alakija T, et al. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet. 1989;2:830-834.
10. Limsomwong N, Pang LW, Singharaj P. Malaria prophylaxis with proguanil in children living in a malaria-endemic area. Am J Trop Med Hyg. 1988;38:231-236.
11. Hamad AA, Nugud Ael H, Arnot DE, et al. A marked seasonality of malaria transmission in two rural sites in eastern Sudan. Acta Trop. 2002;83:71-82.
12. Eke FU, Obamyonyi A, Eke NN, Oyewo EA. An open comparative study of dispersible piroxicam versus soluble acetylsalicylic acid for the treatment of osteoarticular painful attack during sickle cell crisis. Trop Med Int Health. 2000;5:81-84.
13. Okeahialam TC, Okoro BA. Use of Sulphadoxine Pyrimethamine-Combination (FANSIDAR) for Malaria Prophylaxis in Children with Sickle Cell Disease. 10th International Congress on Tropical Medicine and Malaria; March 5-8, 1980, Manilla, Australia.
14. Nicholson JF, Pesce MA. Laboratory medicine and reference tables. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson Textbook of Pediatrics. 15th ed. Philadelphia, Pa: WB Saunders; 1996:2031-2084.
15. Ogbuokiri JE. Pharmacology of antimalaria drugs. In: Obi CC, ed. Rational Use of Antimalaria Drugs. 1st ed. Surulere, Lagos: Tropics Interpharm Services; 1992:58-73.
16. Thong BY, Leong KP, Chng HH. Hypersensitivity syndrome associated with dapsone/ pyrimethamine (Maloprim) antimalaria chemoprophylaxis. Ann Allergy Asthma Immunol. 2002;88:527-529,
17. Ahmed SM, Abd Al-Rhim SK, Mohamedani AA, et al. Malaria parasitemia during delivery. Saudi Med J. 2002;23:684-688.
18. Hyde JE. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes Infect. 2002;4:165-174.
19. World Health Organization Malaria Action Program. Severe and complicated malaria. Trans R Soc Trop Med Hyg. 1986;80(Suppl):17-26.
20. Peters W. Malaria vaccination: Two steps forward, one backward. BMJ. 1983;287: 1089-1090.
21. Lege-Oguntoye L, Adagu SI, Werblinska B, et al. Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine combination in semi-immune children in Zaria, northern Nigeria. Trans R Soc Trop Med Hyg. 1990;84:505-506.
22. Sowunmi A, Oduola AM, Ogundahunsi OA, Salako LA. Enhancement of the antimalarial effect of chloroquine by chlorpheniramine in vivo. Trop Med Int Health, 1998;3: 177-183.
23. Easterbrook M. Ocular effects and safety of antimalarial agents. Am J Med. 1988; 85:23-29.
24. Wernsdorfer WH. Current approaches to malaria chemotherapy and prophylaxis. Parasitology Today. 1986;2:250-253.
25. Jones SA. Pyrimethamine resistant strains of human malaria. Trans R Soc Trop Med Hyg. 1968;62:572.
26. Geerligs PD, Brabin BJ, Eggelte TA. Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull World Health Organ. 2003;81:205-216.
27. Salako LA, Ajayi FO, Sowunmi A, Walker O. Malaria in Nigeria: A revisit. Ann Trop Med Parasitol. 1990;84:435-445.